Drug Type Small molecule drug |
Synonyms M 3541, M3541 |
Target |
Action inhibitors |
Mechanism ATM inhibitors(Serine-protein kinase ATM inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 1 |
First Approval Date- |
Regulation- |
Molecular FormulaC23H17FN6O2 |
InChIKeyOOCGUVCGJIUQKC-UHFFFAOYSA-N |
CAS Registry1360628-91-6 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Solid tumor | Phase 1 | United States | 06 Sep 2017 |
Phase 1 | 15 | Palliative Radiotherapy (RT)+M3541 (M3541 50 mg + RT) | viuqwsfimj = xrcadfftjz ledfyadkmg (ensgbyztyr, uyrrbbyuyd - wzogwdgckm) View more | - | 22 Nov 2023 | ||
Palliative Radiotherapy (RT)+M3541 (M3541 100 mg + RT) | viuqwsfimj = tdjjobtfxa ledfyadkmg (ensgbyztyr, wxftsqhvly - oxgawkzawd) View more | ||||||
Phase 1 | 15 | Radiotherapy+M 3541 | zetrvjrniq(siemagdqhg) = tgwuiisevp qdratkadyz (azjcvvzeid ) View more | Negative | 12 Feb 2022 |